Dr. Janice Kwon is a Professor and Gynecologic Oncologist at the University of British Columbia, Vancouver General Hospital and BC Cancer in Vancouver.  She completed her fellowship training at the University of Toronto, Masters degree in Public Health at Harvard, and post-doctorate at the M.D. Anderson Cancer Center in Houston.  She is co-chair of the National BRCA+ Collaborative in Canada which is involved in education and advocacy around genetic testing and ovarian cancer prevention.

Dr. Tessier-Cloutier completed his training in gynecologic pathology at the University of British Columbia and Memorial Sloan Kettering Cancer Center. He is now a consultant Gynecologic Pathologist at the McGill University Health Centre (MUHC) and principal investigator at the Research Institute (RI-MUHC). His research focuses on the morphologic and molecular profiling of aggressive gynecologic malignancies and experimental model development. His research is supported by the CIHR, FRQS, as well as the TFRI foundation.

Melica Brodeur is an Assistant Professor in the Department of Obstetrics & Gynecology and the Department of Oncology at McGill University. She is an attending Gynecologic Oncologist and a Principal Investigator at the Jewish General Hospital and Lady Davis Institute for Medical Research where she practices as a clinician-scientist.

She completed her medical degree at McGill University following which she undertook her Obstetrics & Gynecology residency at the University of British Columbia. She pursued a subspecialty in Gynecologic Oncology at the Université de Montréal during which she supplemented her training through the Clinician-Investigator Program with a master’s in biomedical sciences working in the laboratory of Dr. Anne-Marie Mes-Masson. Her interests in translational research led her to complete a postdoctoral research fellowship at the Memorial Sloan Kettering Cancer Center under the direction of Drs Britta Weigelt and Dmitriy Zamarin.

Her research focuses on understanding treatment response in gynecologic cancers and discovering new therapeutic targets and treatment strategies to overcome therapy failure. She co-leads the Gynecologic Oncology Research Laboratory at the Lady Davis Institute for Medical Research and is co-director of the Gynecologic Tumor Biobank.

Alexandria Tadman is the Government Relations and Advocacy Lead at Ovarian Cancer Canada, where she has been driving advocacy efforts since 2022. With a strong foundation in the not-for-profit sector both in Canada and internationally and a joint Master’s degree, Alexandria brings a wealth of experience in health policy and system change. Prior to joining OCC, she spent five years with the Ontario Provincial Government, including as a Senior Policy Advisor at the Ministry of Health. Passionate about improving healthcare through collaboration, she works closely with patient advocates to advance meaningful change.